Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. The company operates through four segments: Retail; Group and Specialty; Healthcare Services; and Individual Commercial. The Retail segment offers Medicare and supplemental benefit plans to individuals or through group accounts. This segment also has contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. The Group and Specialty segment provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health and voluntary insurance benefits; financial protection products; and administrative services only products to individuals and employer groups. It also offers military services, such as TRICARE South Region contract. The Healthcare Services segment provides pharmacy solutions, provider services, predictive modeling and informatics services, and clinical care services, such as home health and other services to its health plan members, as well as to third parties. The Individual Commercial segment offers individual commercial fully-insured medical health insurance benefits under the HumanaOne brand. The company also provides closed-block long-term care insurance policies. As of December 31, 2017, it had approximately 14 million members in medical benefit plans, as well as approximately 7 million members in specialty products. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.
Industry, Sector and Symbol
Industry Hospital & medical service plans
Sub-IndustryManaged Health Care
SectorMedical
SymbolNYSE:HUM
CUSIP44485910
Phone502-580-1000
Debt
Debt-to-Equity Ratio0.48%
Current Ratio1.85%
Quick Ratio1.85%
Price-To-Earnings
Trailing P/E Ratio25.19
Forward P/E Ratio21.28
P/E Growth1.6
Sales & Book Value
Annual Sales$53.77 billion
Price / Sales0.76
Cash Flow$15.2692 per share
Price / Cash19.32
Book Value$68.89 per share
Price / Book4.28
Profitability
EPS (Most Recent Fiscal Year)$11.71
Net Income$2.45 billion
Net Margins4.55%
Return on Equity16.13%
Return on Assets5.49%
Miscellaneous
Employees45,900
Outstanding Shares137,680,000
Humana (NYSE:HUM) Frequently Asked Questions
What is Humana's stock symbol?
Humana trades on the New York Stock Exchange (NYSE) under the ticker symbol "HUM."
How often does Humana pay dividends? What is the dividend yield for Humana?
Humana declared a quarterly dividend on Tuesday, February 6th. Stockholders of record on Friday, March 30th will be given a dividend of $0.50 per share on Friday, April 27th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.68%. The ex-dividend date is Wednesday, March 28th. This is a positive change from Humana's previous quarterly dividend of $0.40. View Humana's Dividend History.
How will Humana's stock buyback program work?
Humana announced that its board has initiated a share buyback program on Friday, December 15th 2017, which allows the company to buyback $3,000,000,000.00 in shares, according to EventVestor. This buyback authorization allows the company to repurchase shares of its stock through open market purchases. Shares buyback programs are generally a sign that the company's board believes its shares are undervalued.
How were Humana's earnings last quarter?
Humana (NYSE:HUM) issued its quarterly earnings results on Wednesday, February, 7th. The insurance provider reported $2.06 earnings per share for the quarter, beating analysts' consensus estimates of $2.00 by $0.06. The insurance provider earned $13.19 billion during the quarter, compared to analyst estimates of $13.14 billion. Humana had a return on equity of 16.13% and a net margin of 4.55%. The business's revenue was up 2.4% compared to the same quarter last year. During the same period in the prior year, the company earned $2.34 EPS. View Humana's Earnings History.
When is Humana's next earnings date?
What guidance has Humana issued on next quarter's earnings?
Humana updated its FY18 earnings guidance on Thursday, March, 1st. The company provided earnings per share (EPS) guidance of $13.40-14.00 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $13.86.
What price target have analysts set for HUM?
18 analysts have issued 1 year price targets for Humana's stock. Their predictions range from $221.00 to $330.00. On average, they anticipate Humana's share price to reach $274.8889 in the next twelve months. View Analyst Ratings for Humana.
What are Wall Street analysts saying about Humana stock?
Here are some recent quotes from research analysts about Humana stock:
- 1. According to Zacks Investment Research, "Humana’s shares have outperformed the industry year to date. The company is well poised to grow on its strong government business. Its top line has been witnessing an uptrend for past many years. Sufficient generation of cash flow has helped the company take up several capital deployment initiatives aimed at enhancing shareholders’ value. Humana’s sound balance sheet and disciplined capital management remain major tailwinds. Following decent 2017 results, the company provided strong guidance for 2018. However, the company's individual commercial business has remained a drag over past few years. Rising level of expenses also continues to weigh on the bottom line." (4/13/2018)
- 2. Cantor Fitzgerald analysts commented, "4Q17 results recap. 4Q17 revenue was $13 billion vs. our estimate of $13.8 billion and consensus of $13.2 billion. Retail segment revenue grew 3% and individual MA membership grew 1%. January 2018 individual MA membership grew about 5.7% from year end levels, which is impressive. Group MA membership grew nicely in 2017. January 2018 Group MA membership grew another 12% sequentially. MLR was slightly below our estimate and operating costs were essentially in line. 4Q17 EPS was $2.06 vs. our estimate of $1.97 and consensus of $2.00." (2/7/2018)
Who are some of Humana's key competitors?
Some companies that are related to Humana include CSL (CSL), Celgene (CELG), GlaxoSmithKline (GSK), Becton Dickinson (BDX), Stryker (SYK), Anthem (ANTM), Allergan (AGN), Aetna (AET), Biogen (BIIB), Intuitive Surgical (ISRG), Shire (SHPG), Fresenius (FSNUY), Vertex Pharmaceuticals (VRTX), Zoetis (ZTS), Beximco Pharmaceuticals (BXP), Express Scripts (ESRX), Boston Scientific (BSX) and Takeda Pharmaceutical (TKPYY).
Who are Humana's key executives?
Humana's management team includes the folowing people:
- Mr. Bruce Dale Broussard, Pres, CEO & Director (Age 56)
- Mr. Brian Andrew Kane, Sr. VP & CFO (Age 45)
- Mr. Timothy S. Huval, Chief HR Officer (Age 52)
- Ms. Jody L. Bilney, Chief Consumer Officer (Age 57)
- Mr. James Elmer Murray, Advisor (Age 64)
Has Humana been receiving favorable news coverage?
Headlines about HUM stock have been trending somewhat positive on Thursday, Accern Sentiment Analysis reports. Accern scores the sentiment of media coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Humana earned a coverage optimism score of 0.07 on Accern's scale. They also gave news articles about the insurance provider an impact score of 45.82 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company's share price in the immediate future.
How do I buy shares of Humana?
Shares of HUM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Humana's stock price today?
One share of HUM stock can currently be purchased for approximately $295.00.
How big of a company is Humana?
Humana has a market capitalization of $40.79 billion and generates $53.77 billion in revenue each year. The insurance provider earns $2.45 billion in net income (profit) each year or $11.71 on an earnings per share basis. Humana employs 45,900 workers across the globe.
How can I contact Humana?
Humana's mailing address is 500 West Main Street, LOUISVILLE KY, 40202. The insurance provider can be reached via phone at 502-580-1000.
MarketBeat Community Rating for Humana (HUM)
MarketBeat's community ratings are surveys of what our community members think about Humana and other stocks. Vote "Outperform" if you believe HUM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HUM will underperform the S&P 500 over the long term. You may vote once every thirty days.
Humana (NYSE:HUM) Price Target and Consensus Rating
(How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
18 Wall Street analysts have issued ratings and price targets for Humana in the last 12 months. Their average twelve-month price target is $274.8889, suggesting that the stock has a possible downside of 6.82%. The high price target for HUM is $330.00 and the low price target for HUM is $221.00. There are currently 5 hold ratings and 13 buy ratings for the stock, resulting in a consensus rating of "Buy."
| Today | 30 Days Ago | 90 Days Ago | 180 Days Ago |
| Consensus Rating: | Buy | Buy | Buy | Buy |
| Consensus Rating Score: | 2.72 | 2.74 | 2.65 | 2.57 |
| Ratings Breakdown: | 0 Sell Rating(s)
5 Hold Rating(s)
13 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
5 Hold Rating(s)
14 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
7 Hold Rating(s)
13 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
9 Hold Rating(s)
12 Buy Rating(s)
0 Strong Buy Rating(s) |
| Consensus Price Target: | $274.8889 | $269.1667 | $258.1579 | $252.95 |
| Price Target Upside: | 6.82% downside | 1.45% upside | 2.66% downside | 6.65% upside |
Humana (NYSE:HUM) Consensus Price Target History
Humana (NYSE:HUM) Analyst Ratings History
Show:
(Data available from 4/19/2016 forward)
Humana (NYSE:HUM) Dividend Information
Humana pays an annual dividend of $2.00 per share, with a dividend yield of 0.68%. HUM's next quarterly dividend payment will be made on Friday, July 27. The company has grown its dividend for the last 7 consecutive years and is increasing its dividend by an average of 10.60% each year. Humana pays out 17.08% of its earnings out as a dividend.
| Next Dividend: | 7/27/2018 |
| Annual Dividend: | $2.00 |
| Dividend Yield: | 0.68% |
| Dividend Growth: | 10.60% (3 Year Average) |
| Payout Ratio: | 17.08% (Trailing 12 Months of Earnings)
14.43% (Based on This Year's Estimates)
12.05% (Based on Next Year's Estimates)
|
| Track Record: | 7 Years of Consecutive Dividend Growth |
| Frequency: | Quarterly Dividend |
Humana (NYSE:HUM) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
| 4/19/2018 | quarterly | $0.50 | 0.68% | | 6/29/2018 | 7/27/2018 |
| 2/6/2018 | Quarterly | $0.50 | 0.74% | 3/28/2018 | 3/30/2018 | 4/27/2018 |
| 11/2/2017 | quarterly | $0.40 | 0.62% | 12/28/2017 | 12/29/2017 | 1/26/2018 |
| 8/17/2017 | | $0.40 | | 9/28/2017 | 9/29/2017 | 10/16/2017 |
| 8/17/2017 | quarterly | $0.40 | 0.65% | 9/28/2017 | 8/29/2017 | 10/27/2017 |
| 4/20/2017 | quarterly | $0.40 | 0.75% | 6/28/2017 | 6/30/2017 | 7/31/2017 |
| 2/15/2017 | quarterly | $0.40 | 0.78% | 3/29/2017 | 3/31/2017 | 4/28/2017 |
| 10/26/2016 | quarterly | $0.29 | 0.67% | 1/10/2017 | 1/12/2017 | 1/27/2017 |
| 8/25/2016 | quarterly | $0.29 | 0.65% | 10/11/2016 | 10/13/2016 | 10/28/2016 |
| 4/21/2016 | quarterly | $0.29 | 0.66% | 6/28/2016 | 6/30/2016 | 7/29/2016 |
| 2/18/2016 | quarterly | $0.29 | 0.7% | 3/29/2016 | 3/31/2016 | 4/29/2016 |
| 10/29/2015 | quarterly | $0.29 | 0.65% | 12/28/2015 | 12/30/2015 | 1/29/2016 |
| 8/27/2015 | quarterly | $0.29 | 0.63% | 9/28/2015 | 9/30/2015 | 10/30/2015 |
| 4/17/2015 | quarterly | $0.29 | 0.65% | 6/26/2015 | 6/30/2015 | 7/31/2015 |
| 2/18/2015 | quarterly | $0.28 | 0.73% | 3/27/2015 | 3/31/2015 | 4/24/2015 |
| 10/31/2014 | quarterly | $0.28 | 0.81% | 12/29/2014 | 12/31/2014 | 1/30/2015 |
| 8/27/2014 | quarterly | $0.28 | 0.88% | 9/26/2014 | 9/30/2014 | 10/31/2014 |
| 4/30/2014 | quarterly | $0.28 | 1.02% | 6/26/2014 | 6/30/2014 | 7/25/2014 |
| 2/19/2014 | quarterly | $0.27 | 1.06% | 3/27/2014 | 3/31/2014 | 4/25/2014 |
| 10/30/2013 | quarterly | $0.27 | 1.17% | 12/27/2013 | 12/31/2013 | 1/31/2014 |
| 8/22/2013 | quarterly | $0.27 | 1.14% | 9/26/2013 | 9/30/2013 | 10/25/2013 |
| 4/25/2013 | quarterly | $0.27 | 1.47% | 6/26/2013 | 6/28/2013 | 7/26/2013 |
| 2/27/2013 | quarterly | $0.26 | 1.52% | 3/26/2013 | 3/28/2013 | 4/26/2013 |
(Data available from 1/1/2013 forward)
Humana (NYSE HUM) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 0.60%
Institutional Ownership Percentage: 96.42%
Humana (NYSE HUM) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 3/9/2018 | Cynthia H Zipperle | SVP | Sell | 1,196 | $273.33 | $326,902.68 | 7,771 |  |
| 2/27/2018 | M Todoroff Christopher | Insider | Sell | 16,389 | $273.37 | $4,480,260.93 | 13,447 | |
| 2/26/2018 | Bruce D Broussard | CEO | Sell | 14,075 | $274.32 | $3,861,054.00 | 113,896 | |
| 12/21/2017 | Brian P Leclaire | SVP | Sell | 1,679 | $245.97 | $412,983.63 | 9,888 | |
| 12/19/2017 | Timothy S Huval | VP | Sell | 1,382 | $246.04 | $340,027.28 | 11,557 | |
| 12/18/2017 | Jody L Bilney | SVP | Sell | 7,054 | $247.89 | $1,748,616.06 | 11,704 | |
| 9/1/2017 | Elizabeth D Bierbower | Insider | Sell | 9,786 | $259.00 | $2,534,574.00 | 18,042 | |
| 9/1/2017 | Timothy S Huval | VP | Sell | 7,803 | $258.14 | $2,014,266.42 | 8,831 | |
| 8/23/2017 | William Kevin Fleming | Insider | Sell | 3,071 | $250.98 | $770,759.58 | 7,681 | |
| 8/11/2017 | Bruce D Broussard | CEO | Sell | 12,000 | $251.88 | $3,022,560.00 | 80,086 | |
| 8/10/2017 | M Todoroff Christopher | VP | Sell | 22,935 | $252.52 | $5,791,546.20 | 24,001 | |
| 6/28/2017 | Brian P Leclaire | SVP | Sell | 4,971 | $240.00 | $1,193,040.00 | 14,258 | |
| 5/26/2017 | Heidi S Margulis | VP | Sell | 1,500 | $231.96 | $347,940.00 | 8,150 | |
| 5/5/2017 | Jody L Bilney | SVP | Sell | 4,600 | $230.16 | $1,058,736.00 | 8,978 | |
| 5/4/2017 | Bruce D Broussard | CEO | Sell | 118,231 | $225.82 | $26,698,924.42 | 171,170 | |
| 5/4/2017 | Timothy S Huval | VP | Sell | 13,939 | $225.86 | $3,148,262.54 | 23,639 | |
| 3/21/2017 | Jody L Bilney | SVP | Sell | 4,348 | $213.80 | $929,602.40 | 13,578 | |
| 3/6/2017 | James E Murray | COO | Sell | 31,151 | $213.62 | $6,654,476.62 | 45,635 | |
| 3/3/2017 | Cynthia H Zipperle | VP | Sell | 1,885 | $213.37 | $402,202.45 | 3,736 | |
| 2/24/2017 | Brian P Leclaire | SVP | Sell | 4,971 | $204.81 | $1,018,110.51 | 14,258 | |
| 2/22/2017 | Brian P Leclaire | SVP | Sell | 26,894 | $205.24 | $5,519,724.56 | 25,734 | |
| 2/22/2017 | James E Murray | COO | Sell | 9,523 | $204.69 | $1,949,262.87 | 76,798 | |
| 2/22/2017 | Roy A Beveridge | VP | Sell | 4,832 | $205.73 | $994,087.36 | 18,439 | |
| 2/21/2017 | Bruce D Broussard | CEO | Sell | 104,256 | $205.23 | $21,396,458.88 | 155,108 | |
| 2/21/2017 | Cynthia H Zipperle | CAO | Sell | 4,213 | $204.67 | $862,274.71 | 6,542 | |
| 2/21/2017 | David A. Jr/Ky Jones | Director | Sell | 27,000 | $205.04 | $5,536,080.00 | | |
| 2/21/2017 | James E Murray | COO | Sell | 70,332 | $205.20 | $14,432,126.40 | 76,798 | |
| 2/21/2017 | Jody L Bilney | SVP | Sell | 6,087 | $204.72 | $1,246,130.64 | 28,577 | |
| 2/21/2017 | M Todoroff Christopher | VP | Sell | 24,140 | $205.33 | $4,956,666.20 | | |
| 2/25/2016 | Brian P Leclaire | SVP | Sell | 183 | $176.11 | $32,228.13 | 17,301 | |
| 3/11/2015 | James E Murray | COO | Sell | 35,220 | $160.90 | $5,666,898.00 | | |
| 3/2/2015 | Brian P Leclaire | SVP | Sell | 5,500 | $161.79 | $889,845.00 | | |
| 2/25/2015 | Bruce D Broussard | CEO | Sell | 41,105 | $165.29 | $6,794,245.45 | | |
| 2/25/2015 | David A Jr/Ky Jones | Director | Sell | 6,100 | $165.39 | $1,008,879.00 | | |
| 2/24/2015 | Heidi S Margulis | VP | Sell | 3,665 | $164.44 | $602,672.60 | | |
| 8/22/2014 | Brian P Leclaire | SVP | Sell | 3,250 | $123.04 | $399,880.00 | | |
| 5/15/2014 | Heidi Margulis | VP | Sell | 3,345 | $119.56 | $399,928.20 | 8,730 | |
| 5/12/2014 | Marissa Peterson | Director | Sell | 2,026 | $123.30 | $249,805.80 | 1,358 | |
| 3/19/2014 | James Murray | COO | Sell | 36,833 | $116.59 | $4,294,359.47 | 89,892 | |
| 3/18/2014 | M Todoroff Christopher | VP | Sell | 8,000 | $113.20 | $905,600.00 | 18,225 | |
| 3/13/2014 | Bruce Broussard | CEO | Sell | 109,000 | $109.84 | $11,972,560.00 | 59,944 | |
| 3/10/2014 | Webster Roy Dunbar | Director | Sell | 9,587 | $110.30 | $1,057,446.10 | 1,458 | |
| 12/4/2013 | Marissa Peterson | Director | Sell | 1,147 | $103.54 | $118,760.38 | | |
| 12/2/2013 | M Todoroff Christopher | VP | Sell | 6,000 | $105.50 | $633,000.00 | 16,226 | |
| 11/26/2013 | Heidi Margulis | VP | Sell | 5,500 | $104.42 | $574,310.00 | 7,136 | |
| 11/8/2013 | David Jr/Ky Jones | Director | Sell | 11,000 | $95.00 | $1,045,000.00 | 143,339 | |
| 9/5/2013 | Elizabeth D Bierbower | Insider | Sell | 17,673 | $96.01 | $1,696,784.73 | | |
| 8/30/2013 | Heidi Margulis | VP | Sell | 3,319 | $93.35 | $309,828.65 | 10,801 | |
| 8/29/2013 | David Jr/Ky Jones | Director | Sell | 2,500 | $93.01 | $232,525.00 | 154,339 | |
| 8/23/2013 | Elizabeth Bierbower | Insider | Sell | 6,063 | $94.00 | $569,922.00 | 16,473 | |
| 8/15/2013 | Michael Mccallister | Director | Sell | 138,817 | $91.49 | $12,700,367.33 | 111,859 | |
| 8/13/2013 | Bruce Perkins | Insider | Sell | 9,000 | $93.47 | $841,230.00 | 10,985 | |
| 8/8/2013 | Steven Mcculley | VP | Sell | 10,000 | $92.54 | $925,400.00 | 9,327 | |
| 8/7/2013 | James Bloem | CFO | Sell | 33,000 | $91.79 | $3,029,070.00 | 21,767 | |
| 8/1/2013 | M Todoroff Christopher | VP | Sell | 39,596 | $90.30 | $3,575,518.80 | | |
| 6/24/2013 | Paul B K Kusserow | SVP | Sell | 34,219 | $84.60 | $2,894,927.40 | | |
| 6/18/2013 | Elizabeth D Bierbower | Insider | Sell | 8,033 | $83.29 | $669,068.57 | | |
| 5/30/2013 | James E Murray | COO | Sell | 11,000 | $81.96 | $901,560.00 | | |
| 5/9/2013 | Michael B Mccallister | Director | Sell | 281,312 | $77.72 | $21,863,568.64 | | |
(Data available from 1/1/2013 forward)
Humana (NYSE HUM) News Headlines
| Source: |
|
| Date | Headline |
|---|
 | Humana Board Declares Payment of Quarterly Dividend to Stockholders
finance.yahoo.com - April 19 at 4:40 PM |
 | Zacks Investment Research Lowers Humana (HUM) to Hold
www.americanbankingnews.com - April 17 at 5:25 PM |
| The Long-Term Bull Driving Humana Is Back With New Price Targets
finance.yahoo.com - April 17 at 9:33 AM |
| Analyzing UNH Stock’s Recent Performance
finance.yahoo.com - April 17 at 9:33 AM |
| Humana (HUM) Expected to Earn Q1 2018 Earnings of $3.21 Per Share
www.americanbankingnews.com - April 17 at 6:45 AM |
 | Humana (HUM) PT Raised to $330 at Argus
www.streetinsider.com - April 16 at 9:38 AM |
| Humana (HUM) Price Target Raised to $330.00
www.americanbankingnews.com - April 16 at 9:16 AM |
| Humana (HUM) Stock Rating Lowered by Zacks Investment Research
www.americanbankingnews.com - April 15 at 5:06 PM |
| Humana (HUM) Given Average Rating of "Buy" by Analysts
www.americanbankingnews.com - April 15 at 5:45 AM |
| Humana (HUM) Stock Rating Lowered by BidaskClub
www.americanbankingnews.com - April 14 at 10:53 PM |
| Humana (HUM) Price Target Raised to $280.00 at Piper Jaffray
www.americanbankingnews.com - April 13 at 7:49 PM |
| Oppenheimer Increases Humana (HUM) Price Target to $255.00
www.americanbankingnews.com - April 13 at 5:29 PM |
| Humana (HUM) Upgraded to Buy at Zacks Investment Research
www.americanbankingnews.com - April 13 at 11:12 AM |
| FY2019 EPS Estimates for Humana (HUM) Raised by Analyst
www.americanbankingnews.com - April 13 at 9:45 AM |
 | Humana Expands Availability of Value-Based Orthopedic Specialty Care to Improve Patient Experience in Seven ...
www.businesswire.com - April 12 at 4:37 PM |
 | 5 Ways A Walmart-Humana Partnership Could Change Everyone's In-Store Experience
www.forbes.com - April 12 at 4:37 PM |
| Humana Expands Availability of Value-Based Orthopedic Specialty Care to Improve Patient Experience in Seven Additional States
finance.yahoo.com - April 12 at 10:12 AM |
 | Humana expands Medicare business with acquisition of physicians group
www.bizjournals.com - April 11 at 4:35 PM |
| Humana (HUM) Shores Up Government Business With FPG Buyout
finance.yahoo.com - April 11 at 4:34 PM |
| Humana Buys More Doctor Practices Amid Walmart Speculation
finance.yahoo.com - April 11 at 10:02 AM |
 | Humana acquires Florida family physician group
seekingalpha.com - April 11 at 12:31 AM |
| Humana (HUM) Upgraded by BidaskClub to "Hold"
www.americanbankingnews.com - April 10 at 9:26 PM |
 | BRIEF-Humana Acquires Family Physicians Group In Central Florida
www.reuters.com - April 10 at 4:32 PM |
| Humana Acquires Family Physicians Group in Central Florida
finance.yahoo.com - April 10 at 4:32 PM |
| Humana (HUM) Expected to Post Quarterly Sales of $14.12 Billion
www.americanbankingnews.com - April 10 at 2:17 AM |
| Humana (HUM) Lifted to Hold at BidaskClub
www.americanbankingnews.com - April 9 at 10:19 PM |
| Zacks: Analysts Expect Humana (HUM) to Announce $3.21 Earnings Per Share
www.americanbankingnews.com - April 8 at 9:14 PM |
| Humana (HUM) Stock Rating Lowered by JPMorgan Chase
www.americanbankingnews.com - April 7 at 8:50 PM |
| Humana (HUM) Cut to "Hold" at ValuEngine
www.americanbankingnews.com - April 7 at 8:50 PM |
| Humana (HUM) Given Hold Rating at Royal Bank of Canada
www.americanbankingnews.com - April 7 at 7:47 PM |
| Humana (HUM) Rating Reiterated by Piper Jaffray
www.americanbankingnews.com - April 4 at 6:26 AM |
| Humana (HUM) Raised to Buy at ValuEngine
www.americanbankingnews.com - April 3 at 1:55 PM |
 | The Biggest Movers: Humana Jumps, Nektar Tumbles
www.barrons.com - April 3 at 9:36 AM |
| Humana Deal Could Bring Walmart Into Patient Homes For Care
www.forbes.com - April 3 at 9:36 AM |
 | Stock market kicks off April trade mostly lower; Humana's stock jumps on report of Walmart interest
www.marketwatch.com - April 2 at 4:36 PM |
| Hospital operators anxiously eyeing Walmart - Humana deal
seekingalpha.com - April 2 at 12:52 PM |
 | Stocks to Watch: Walmart, Humana, Tesla, Amazon, Facebook, Under Armour, Nike, Cal-Maine Foods
www.wsj.com - April 2 at 10:08 AM |
 | Stocks slip in early trading; Humana jumps, and Tesla falls
www.latimes.com - April 2 at 10:08 AM |
| UnitedHealth's Optum And Humana In Blockchain Deal To Improve Doctor Directories
www.forbes.com - April 2 at 10:08 AM |
 | Markets Right Now: Stocks edge lower in early trading
marketbeat.com - April 2 at 9:57 AM |
 | Humana, health insurer shares surge on Walmart's potential bid
www.cnbc.com - April 2 at 9:19 AM |
| Sell-siders weigh in on potential Walmart - Humana tie-up
seekingalpha.com - April 2 at 9:03 AM |
| Insurers will study blockchain to fix their provider lists
www.cnbc.com - April 2 at 1:36 AM |
 | Threats From All Sides Push Walmart and Humana Closer Together
www.bloomberg.com - April 1 at 4:38 PM |
| Walmart's potential Humana deal could connect your health insurance with the produce aisle
www.marketwatch.com - April 1 at 9:28 AM |
| Walmart in talks to buy insurer Humana: report
finance.yahoo.com - April 1 at 9:28 AM |
| Hospitals Fear Threat From Potential Walmart-Humana Deal
finance.yahoo.com - April 1 at 9:27 AM |
| Humana (HUM) Rating Reiterated by Royal Bank of Canada
www.americanbankingnews.com - March 31 at 6:06 PM |
| Humana (HUM) Price Target Cut to $270.00 by Analysts at Morgan Stanley
www.americanbankingnews.com - March 31 at 5:28 PM |
| Head to Head Analysis: Trupanion (TRUP) and Humana (HUM)
www.americanbankingnews.com - March 31 at 5:12 PM |
Humana (NYSE:HUM) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Humana (NYSE:HUM) Income Statement, Balance Sheet and Cash Flow Statement
Humana (NYSE HUM) Stock Chart for Thursday, April, 19, 2018
Loading chart…
